ASCO 2014 roundup

Adjuvant exemestane more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer

Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC

Emerging pathways in immunotherapy

Checkpoint blockade: a concept or already a reality?

Cancer evasion of the immune system: the fundamentals

Myeloma genomics and Immuno-oncology

Novel targets and immune based therapy in myeloma

Recent advances in mantle cell lymphoma: Expert panel discussion

Lecture: Current standard of care in advanced disease

Lecture: Exploring the androgen signalling pathway in CRPC

Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC